Evaluation of WATCHMAN Left Atrial Appendage Occlusion Device in Patients With Atrial Fibrillation Versus Rivaroxaban
Clinical trial NCT02549963 · UNKNOWN
Trial details
- NCT number
- NCT02549963
- Sponsor
- Shulin Wu
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2017-10-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.